Azioni Islet Sciences Inc

Azioni

Tempo differito OTC Markets Altri mercati azionari 15:53:58 26/07/2017			Variaz. 5gg	Var. 1 gen.
0,0127 ^USD	+5,75%		+5,75%	-76,93%

Durata

Periodo

Stile

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04/05/15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23/04/15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24/03/15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09/03/15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05/03/15

1 giorno

+5,75%

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	+1,51%	42,75 Mrd
LONZA GROUP AG	+49,22%	41,61 Mrd
MODERNA, INC.	+8,57%	41,34 Mrd
CELLTRION, INC.	-12,36%	26,59 Mrd
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 Mrd
MEDPACE HOLDINGS, INC.	+29,17%	12,24 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 Mrd
UNITED THERAPEUTICS CORPORATION	+6,35%	11 Mrd